Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

NCT01518465 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Insufficient Accrual

Conditions

Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: dalteparin
DRUG: lenalidomide
DRUG: dexamethasone
OTHER: laboratory biomarker analysis

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]